Julia Billiard
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, Growth Hormone and Insulin-like Growth Factors, Cancer, Hypoxia, and Metabolism, Hypothalamic control of reproductive hormones
Most-Cited Works
- → Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells(2014)513 cited
- → Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells(2013)232 cited
- → Acute Control of Insulin-like Growth Factor-I Gene Transcription by Growth Hormone through Stat5b(2003)182 cited
- → Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase(2008)177 cited
- → The Wnt antagonist secreted frizzled‐related protein‐1 controls osteoblast and osteocyte apoptosis(2005)166 cited
- → The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells(2004)164 cited
- → A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation(2009)125 cited
- → Homodimerization of Ror2 Tyrosine Kinase Receptor Induces 14-3-3β Phosphorylation and Promotes Osteoblast Differentiation and Bone Formation(2007)96 cited
- → LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4(2010)94 cited
- → The Orphan Receptor Tyrosine Kinase Ror2 Promotes Osteoblast Differentiation and Enhances ex Vivo Bone Formation(2006)76 cited